Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ICUCW | US
0.00
0.52%
Healthcare
Biotechnology
30/06/2024
21/10/2024
0.04
0.04
0.04
0.04
SeaStar Medical Holding Corporation a medical device company focuses on providing novel solutions and services to treat hyperinflammation and cytokine storm in critically ill patients. The company is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. It is developing products in various therapeutic areas including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure with and without LVAD; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is based in Denver Colorado.
View LessLow Debt to Equity (< 0.25)
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Low negative Beta, possible Low Liquidity (< -0.4)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
304.0%1 month
242.5%3 months
198.8%6 months
230.5%-
-
-
-0.46
0.91
-
-
-
-
-
-
-
-
-
-
-
-
-
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.02
Range1M
0.03
Range3M
0.08
Rel. volume
0.25
Price X volume
328.30
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
OCEAW | OCEAW | Biotechnology | 0.0398 | 0 | 2.58% | n/a | -16.02% |
Nutriband Inc. Warrant | NTRBW | Biotechnology | 1.15 | 0 | 9.52% | n/a | 1.72% |
NKGen Biotech Inc. Warrants | NKGNW | Biotechnology | 0.032 | 0 | 29.03% | n/a | -40.33% |
JSPRW | JSPRW | Biotechnology | 0.21 | 0 | 0.00% | n/a | 2.31% |
Humacyte Inc | HUMAW | Biotechnology | 1.8999 | 0 | 5.55% | n/a | -63.37% |
EyeGate Pharmaceuticals Inc | EYEG | Biotechnology | 36.05 | 0 | -0.92% | n/a | |
COEPW | COEPW | Biotechnology | 0.034 | 0 | 70.85% | n/a | 25.11% |
CELUW | CELUW | Biotechnology | 0.0188 | 0 | 27.03% | n/a | 127.38% |
XOMAP | XOMAP | Biotechnology | 26.24 | 0 | -0.23% | 26.27 | 121.93% |
XOMA Corporation Depositary Shares Rep Series B 8.375% Cumulative Preferred Stock | XOMAO | Biotechnology | 25.5992 | 0 | 0.02% | 25.57 | 121.93% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
No data |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | - | 0.53 | - |
Ent. to Revenue | - | 3,967.00 | - |
PE Ratio | - | 41.03 | - |
Price to Book | - | 15.55 | - |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 198.77 | 72.80 | Riskier |
Debt to Equity | -0.46 | -1.23 | Expensive |
Debt to Assets | 0.91 | 0.25 | Expensive |
Market Cap | - | 3.66B | - |